DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Study to Understand Novel Biomarkers in Researching Dementia

Recruiting

Conditions: Alzheimer Disease
Mild Cognitive Impairment
Dementia

Interventions: Other: Research blood collection
Diagnostic Test: Clinical tau PET
Diagnostic Test: Clinical amyloid test
Other: Cognitive assessments

First Posted Date: 2024-08-09

Last Posted Date: 2025-02-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1800

Registration Number: NCT06547099

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome

Phase 1

Recruiting

Conditions: Vexas Syndrome
VEXAS
E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic Syndrome

Interventions: Drug: Pacritinib

First Posted Date: 2024-08-05

Last Posted Date: 2025-02-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT06538181

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Personalized Cancer Vaccine (PCV) Strategy in Patients with Solid Tumors and Molecular Residual Disease

Phase 1

Recruiting

Conditions: Muscle-Invasive Bladder Carcinoma

Interventions: Biological: Synthetic long peptide personalized cancer vaccine
Drug: Poly ICLC
Device: Signatera assay

First Posted Date: 2024-07-31

Last Posted Date: 2025-03-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT06529822

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

Phase 1

Recruiting

Conditions: Locally Advanced Cervical Carcinoma

Interventions: Radiation: Hypofractionated external beam radiation
Drug: Chemotherapy
Radiation: Image-guided brachytherapy

First Posted Date: 2024-07-31

Last Posted Date: 2025-03-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT06529809

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Recombinant glycosylated human interleukin-7
Drug: Melphalan
Procedure: Autologous hematopoietic cell transplant

First Posted Date: 2024-07-26

Last Posted Date: 2025-04-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT06523699

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 1

Interventions: Behavioral: Standard Diet
Behavioral: Ketogenic Diet

First Posted Date: 2024-07-16

Last Posted Date: 2025-02-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 58

Registration Number: NCT06503809

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

Phase 2

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Elrantamab
Device: clonoSEQ

First Posted Date: 2024-07-03

Last Posted Date: 2024-12-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 65

Registration Number: NCT06483100

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Phase 2

Not yet recruiting

Conditions: Kaposi Sarcoma

Interventions: Drug: Propranolol Hydrochloride

First Posted Date: 2024-06-06

Last Posted Date: 2025-04-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25

Registration Number: NCT06445166

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Examining the Role of Pain in the Link Between Early Childhood Adversity and Psychopathology

Not Applicable

Recruiting

Conditions: Child Development

Interventions: Behavioral: Parental Support Cold Pressor Task

First Posted Date: 2024-06-06

Last Posted Date: 2024-06-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT06445712

Locations: 🇺🇸
Laboratory for Child Brain Development, Saint Louis, Missouri, United States

Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl

Recruiting

Conditions: Alzheimer Disease

Interventions: Drug: 18F-Fluselenamyl

First Posted Date: 2024-06-03

Last Posted Date: 2024-06-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 60

Registration Number: NCT06439992

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy